China 3d Printed Drugs Market Size & Outlook, 2023-2030
China 3d printed drugs market, 2018-2030 (US$M)
Related Markets
China 3d printed drugs market highlights
- The China 3d printed drugs market generated a revenue of USD 5.3 million in 2023 and is expected to reach USD 16.5 million by 2030.
- The China market is expected to grow at a CAGR of 17.6% from 2024 to 2030.
- In terms of segment, neurology was the largest revenue generating application in 2023.
- Orthopedic is the most lucrative application segment registering the fastest growth during the forecast period.
3d printed drugs market data book summary
| Market revenue in 2023 | USD 5.3 million |
| Market revenue in 2030 | USD 16.5 million |
| Growth rate | 17.6% (CAGR from 2023 to 2030) |
| Largest segment | Neurology |
| Fastest growing segment | Orthopedic |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Dental, Orthopedic, Neurology |
| Key market players worldwide | GlaxoSmithKline, Hewlett Packard Enterprise Co, Merck KGaA, AstraZeneca PLC, Aprecia Pharmaceuticals, Extend Biosciences, BioDuro, Affini-T Therapeutics, Osmotica Pharmaceutical, FabRx, Cycle Pharmaceuticals |
Other key industry trends
- In terms of revenue, China accounted for 5.1% of the global 3d printed drugs market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan 3d printed drugs market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 2.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
3D Printed Drugs Market Scope
3D Printed Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China 3d printed drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d printed drugs market will help companies and investors design strategic landscapes.
Neurology was the largest segment with a revenue share of 50.94% in 2023. Horizon Databook has segmented the China 3d printed drugs market based on dental, orthopedic, neurology covering the revenue growth of each sub-segment from 2018 to 2030.
China's 3D printed drugs market has observed substantial growth in recent times due to innovation and advancement. China's vast population and increasing healthcare demand, especially for personalized medicine, have created a compelling need for innovative drug manufacturing techniques such as 3D printing.
Moreover, increasing funding from private and public players is anticipated to fuel market growth. For instance, in December 2020, Triastek, Inc., a 3D printing pharmaceutical company in China, raised CNY 100 million or USD 15 million through a Series A+ funding round.
The allocated funds will be utilized to conduct R&D activities for the production of 3D printed pharmaceuticals, submitting registration applications in both China and the U.S., and developing a production line on a large scale. Furthermore, in September 2023, the same company completed a USD 20.4 million Pre-C funding round to enhance its position in the market for 3D printing.
Reasons to subscribe to China 3d printed drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China 3d printed drugs market databook
-
Our clientele includes a mix of 3d printed drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China 3d printed drugs market , including forecasts for subscribers. This country databook contains high-level insights into China 3d printed drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China 3d printed drugs market size, by application, 2018-2030 (US$M)
China 3D Printed Drugs Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
